Connect. Communicate. Conceptualize.
Meet Our Featured Speakers!
Dr Lee Cheng Siang
Scientist, Venn Bioscience Sdn. Bhd.
Dr Lee Cheng Siang graduated with Bachelor of Science (Biochemistry) in 2007, Master of Medical Science (Hormone Biochemistry) in 2010 and PhD in Molecular Medicine in 2017 from Universiti Malaya. Now, he is a translational scientist in Venn Bioscience Sdn. Bhd.
His areas of expertise are in glycoproteomics, mass spectrometry, glycobiology, glycan chemistry, cancer biomarkers, and immunology. In 2007, he was awarded with Best Thesis by the MSBMB-Amersham Bioscience and University of Malaya Fellowship Scheme in 2009.
​
Publications:
​
-
Yap, S.H., Lee, C.S., Aogu Furusho, A., Ishii, C., Shaharudin, S., Zulhaimi, NS., Kamarulzaman, A., Kamaruzzaman, S.B., Mita, M., Leong, K.H., Hamase, K., Rajasuriar, R. (2022). Plasma d-amino acids are associated with markers of immune activation and organ dysfunction in people with HIV.
-
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Lee, C.S. (2021). Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. JAMA.
-
Lavinya, A.A., Lee, C. S., Hashim, O.H., Azwa, I., Rajasuriar, R., Lim, S.K., and Wong, Y.F. (2019). Proteomics analysis of blood plasma in HIV-infected patients with chronic kidney disease. Clin Biochem.
-
Jayapalan, J. J., Lee, C. S., Lee, C. C., Ng, K. L., Junit, S. M., and Hashim, O. H. (2018). iTRAQ analysis of urinary proteins: Potential use of gelsolin and osteopontin to distinguish benign thyroid goiter from papillary thyroid carcinoma. Clin Biochem.
-
Hashim, O. H., Jayapalan, J. J., and Lee, C. S. (2017). Lectins: An Effective Tool for Screening of Potential Cancer Biomarkers. PeerJ.
-
Lee, C. S., Taib, N. A. M., Ali, A., Fadzli, F., Harun, F., Rahmat, K., Hoong, S. M., Abdul-Rahman, P. S. and Hashim, O. H. (2016). Unmasking heavily O-glycosylated serum proteins using perchloric acid: identification of serum proteoglycan 4 and protease C1 inhibitor as molecular indicators for screening of breast cancer. PLoS ONE, 11(2): e0149551.
-
Lee, C. S., Muthusamy, A., Abdul-Rahman, P. S., Bhavananthan, V. and Hashim, O. H. (2013). An improved lectin-based method for the detection of mucin-type O-glycans in biological samples. Analyst, 138, 3522-3529.
-
Saif-Ali R., Muniandy S., Al-Hamodi Z, Lee C. S., Ahmed K. A., Al-Mekhlafi H. M., and Ismail I. S. (2011). KCNQ1 variants associate with type 2 diabetes in Malaysian Malay subjects. Ann Acad Med Singapore, 40: 488-492.
-
Saif-Ali R., Ismail I. S., Al-Hamodi Z., Al-Mekhlafi H M, Lee C. S., Alabsi A. M. and Muniandy S. (2011). KCNQ1 haplotypes associate with type 2 diabetes in Malaysian Chinese subjects. Int. J. Mol. Sci., 12: 5705-5718.
​
Prof. Dr. Fung Shin Yee
Professor at Department of Molecular Medicine, University of Malaya
CTO of Essenti Nutrien Sdn. Bhd
Dr. Fung Shin Yee is a biochemist, receiving her degree from the University of Malaya. She actively pursues her interest in natural compounds focusing on medicinal mushrooms and snake venoms. She obtained her PhD in Molecular Medicine in 2008 (University of Malaya) embarking on a joint project with University of Siena, Italy and is a recipient of a fellowship from the Embassy of Italy in Malaysia (2003-2004).
She leads the Medicinal Mushroom Research Group (MMRG) and has immense interest in the Malaysia’s National Treasure, the Tiger Milk mushroom (Lignosus sp.) amongst other medicinal mushrooms. Her innovative work with Lignosus sp. has won her several prestigious international and local prizes, and Malaysian patents.
​
Her interest also includes other prized medicinal mushroom such as the Ophiocordyceps sinensis and Inonotus obliquus. Her involvement with the Venom and Toxin Research Group (VTRG) in the Department of Molecular Medicine that works on snake venom toxinology has granted her a lucrative experience in the field of toxinology and toxicology; and has propelled her current research interest. Her research endeavours utilize a multidisciplinary approach in her methodology with multiple collaborators both local and international.
​
As a person constantly intrigue by the answers provided by nature for the problems faced in human health and social issues, she strongly believes that nature has many hidden secrets, which if one can tap into, will provide many solutions and platform from which to learn from. This has led her to her primary interest in natural compounds with healing properties. Her work has been published in many articles in international journals and books. She is the Founder and CTO of Essenti Nutrien Sdn. Bhd. who specialises and pioneers the ACE Technology.
Dr Alfred Lee
Country Gene Therapies Lead
Novartis / Novartis Gene Therapies
Dr. Alfred graduated with a doctorate degree (Ph.D) in Molecular Medicine at Universiti Malaya in year 2013. He began his career as a post-doctoral researcher at Faculty of Medicine, Universiti Malaya. He was the project leader for the thyroid cancer study and human hair study.
To progress in his career development, Dr. Alfred joined the pharma industry in 2016 and he has been working across different departments for multiple therapeutic areas. In 2019, he led a team of twelve field-based Medical Scientific Liaisons who serve as medical scientific face of Novartis with Medical Experts, to facilitate the scientific exchange of data & information in various therapeutic areas. His team was recognized as one of the best performing field medical team in Asia Pacific, Middle East & Africa region. Over the years, he has won many awards & recognitions in the industry on his innovative ideas & extensive collaboration with the Malaysia government, hospitals & patient groups. He is always inspired by a quote from Mahatma Gandhi- “Live as if you were to die tomorrow. Learn as if you were to live forever.” Twenty-four hours a day is never enough for him. However, he also found out that spending 2% of a day in exercise could make a big difference in the remaining 98% of that day.